Navigation Links
Study shows how retinoic acid enters a cell's nucleus

sed to the toxic doses currently administered.

"If you can provide a bus to get retinoic acid into the nucleus more efficiently, then you enhance its ability to act as an anti-carcinogen," says Noy. "It's a rapid transport advantage."

Her findings emphasize the importance of efforts in structural genomics, the study of the folding motifs in proteins, which allows researchers to compare 3-D structures of seemingly unrelated proteins. "Advances in structural genomics will allow you to predict what the protein does," Noy says.


'"/>

Source:Cornell University News Service


Page: 1 2 3

Related biology news :

1. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
2. Emory Study Tests Bone Marrow Stem Cells to Improve Circulation in Legs
3. UCLA Study Shows One-Third of Drug Ads in Medical Journals Do Not Contain References Supporting Medical Claims
4. Study Demonstrates Gene Expression Microarrays are Comparable and Reproducible
5. Study Links Ebola Outbreaks To Animal Carcasses
6. Breakthrough Microarray-based Technology for the Study of Cancer
7. NYU Study Reveals How Brains Immune System Fights Viral Encephalitis
8. Study finds more than one-third of human genome regulated by RNA
9. Leukemia Drug Breakthrough Study In New England Journal Of Medicine
10. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
11. New Study from Affymetrix Laboratories Points to Changing View of How Genome Works

Post Your Comments:
(Date:11/4/2009)... Lowly bacteria, it turns out, hold the power to h...around the world clean up toxic waste on test site... RDX, were invented back in World War II and have ...e high-energy compounds are often used to propel t... TNT. , But with increased knowledge of their ...
(Date:11/4/2009)...Y, Calif., Oct. 20 DigitalPersona,...tication solutions, today announced that WAND Corp... software for quick-service restaurants, has integ... POS and Classic POS solutions. WAND,s quick-servi... boost cashier accountability and deter unauthoriz...
(Date:11/4/2009)...ct. 27 Global Rainmakers, Inc., an...d R&D laboratory, today announced that the com... to actively commercialize its suite of technologi...urity offerings. ,, During the past four years,... to develop and deploy a series of core--but expan...
Breaking Biology News(10 mins):Genomic research will enable greener cleanup of military explosive test sites 2WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 2WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 3Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 2Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 3Difficult to treat asthma may be due to difficult to treat patients 59973 1Difficult to treat asthma may be due to difficult to treat patients 59973 2Difficult to treat asthma may be due to difficult to treat patients 59973 3New research suggests how low doses of radiation can cause heart disease and stroke 59969 1New research suggests how low doses of radiation can cause heart disease and stroke 59969 2Side Out Foundation teams with leading medical professionals to battle breast cancer 59965 1Side Out Foundation teams with leading medical professionals to battle breast cancer 59965 2
...ol of Guilderland, N.Y., won the ninth-annual IEEE...nal Engineers Week Future City Competition Nationa...ed for the most "efficient and accurate communicat...pitol Hill. , The team included students Zubin M...neer-mentor Robert Sipzner, PE; and Tom McGreevy, ...
... for decades that the brain has a remarkable abili...s such as traumatic injury. Now, a research articl...nal Genetics ( http://www.genetics.org ) suggest...r problems with key neurotransmitters such as sero...s to entirely new lines of research and treatments...
...ago is launching a large-scale collaboration to de... a wide range of organizations in climate and ener...rant from the John D. and Catherine T. MacArthur F...ommunity Integrated Model of Economic and Resource...support comes from the University and Argonne Nati...
Other Biology News:New York, Florida schools win awards at national student competition 2'Neurological work-arounds' offer hope to people with monoamine-related disorders 2MacArthur Foundation awards planning grant to improve decision-making in energy policy 2MacArthur Foundation awards planning grant to improve decision-making in energy policy 3
(Date:11/6/2009)... Helix BioPharma Corp. (T...ed that John Docherty, president and chief operati... 6th annual Investor Summit on November 10, 2009 a...Mr. Docherty will provide an overview of the Compa...and Topical Interferon Alpha-2b. The slide show p...
(Date:11/6/2009)...6 ,, 3Q09 Corporat...za(TM) E.U. Marketing Authorization to Astellas Ph...mmercial readiness activities Expanded management...ing; and Director, Commercial Operations Appointe...it Committee chairman , Upcoming 2009 Miles...
(Date:11/6/2009)... Intarcia Therapeutics, Inc. delive...® continuous delivery of exenatide) program f...nnual Diabetes Technology Meeting in San Francisco.../prnh/20050301/SFTU126LOGO ) ,, Continuous Su...rs Plasma Glucose, HbA1c and Reduces Weight in a 2...
(Date:11/5/2009)...5 GenVec, Inc. (Nasdaq: ...the third quarter ended September 30, 2009. GenVec...are) for the three months ended September 30, 2009... share) in the comparable quarter of 2008. For the...t loss was $14.1 million ($0.15 per share), compar...
Breaking Biology Technology:Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6
...mo Fisher,Scientific Inc. (NYSE: TMO ), the world... increased to a record $2.62 billion in the fourth...ber 2006 merger with Fisher,Scientific), compared ...ed,earnings per share (EPS) were $.54 in 2007, ver...ncome for the 2007 quarter was $285.0 million,comp...
...enon Pharmaceuticals Inc., a,drug discovery and de...at,it has appointed Charles J. Cohen as Vice Presi...elcome Charlie to the Xenon team," commented,Simon...ngs a unique,combination of drug discovery experie...hly relevant to Xenon such as pain. With a drug ca...
...armaceuticals,Inc. (Nasdaq: ANDS ) announced toda...and Investor Conference on Tuesday, February 12, 2...nce is being held at the Waldorf-Astoria,Hotel in ...ief Executive Officer of Anadys,Pharmaceuticals, I...o,development-stage product candidates, ANA598 and...
Other Biology Technology:Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008 2Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008 3Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008 4Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008 5Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008 6Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008 7Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008 8Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008 9Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008 10Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008 11Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008 12Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008 13Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008 14Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008 15Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008 16Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008 17Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008 18Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008 19Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008 20Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008 21Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008 22Xenon Announces Appointment of VP, Discovery Research 2Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference 2
Weinreb Linker from ChemPep, Inc.
Sheep Anti-Human Factor XIII Antibody, Horseradish Peroxidase Conjugated from CEDARLANE Laboratories Limited
Immunoblot Blocking Reagent from Upstate
Rabbit Anti-DAP12 Polyclonal Antibody, Unconjugated from Exalpha Biologicals, Inc.
Biology Products: